[LXRX] QoQ Quarter Result on 30-Sep-2020 [#Q3]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
30-Oct-2020
Financial Year
2020
Quarter
30-Sep-2020 [#Q3]
Profit Trend
QoQ- 219.59%
YoY- -63.46%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 234 27 199 6,634 9,163 7,999 8,727 -91.06%
PBT -18,067 -20,958 -5,495 82,603 -69,071 -66,611 -51,138 -50.05%
Tax 19 48 -174 4,118 5,125 958 335 -85.26%
NP -18,067 -20,958 -5,495 82,603 -69,071 -66,611 -51,138 -50.05%
Tax Rate - - - -4.99% - - - -
Total Cost 18,301 20,985 5,694 -75,969 78,234 74,610 59,865 -54.65%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin -7,720.94 -77,622.22 -2,761.31 1,245.15 -753.80 -832.74 -585.97 458.74%
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS -0.13 -0.15 -0.04 0.77 -0.65 -0.63 -0.48 -58.17%
EPS Diluted -0.13 -0.15 -0.04 0.71 -0.65 -0.63 -0.48 -58.17%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.